Crossmark

CRSwNP: Mepolizumab kann in Studien überzeugen

Crossref DOI link: https://doi.org/10.1007/s15007-024-6326-x

Published Online: 2024-07-29

Published Print: 2024-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Facharztmagazine, Redaktion
License Information

Text and Data Mining valid from 2024-07-29

Version of Record valid from 2024-07-29
More Information

Article History

First Online: 29 July 2024

Free to read: This content has been made available to all.